한국제약바이오협회

데이터링크

• 
  

  • AMES: The AMES test³⁰ evaluates a compound’s mutagenic potential by assessing whether specific bacteria regain the ability to grow without histidine. It serves as a cost-effective, preliminary toxicity screening method widely used in various industries, particularly in drug development, to identify potential carcinogens. A positive AMES result indicates that the compound may have mutagenic potential, characterized by abnormal bacterial growth speed. We have included 9,139 molecules for the AMES test.